Alzheimer's disease research in the context of the national plan to address Alzheimer's disease

Molecular Aspects of Medicine

Volumn 43-44, Issue , 2015, Pages 16-24

  Snyder, Heather M ^a   Hendrix, James ^a   Bain, Lisa J ^b   Carrillo, Maria C ^a  

^a ALZHEIMER'S ASSOCIATION   (United States)

^b Independent Science Writer   (United States)

Author keywords

Alzheimer's disease; Biomarkers; Collaborations; Dementia; Genetics; Partnerships; Prevention

Indexed keywords

BIOLOGICAL MARKER;

ALZHEIMER DISEASE; DEMENTIA; DISEASE SEVERITY; EARLY DIAGNOSIS; FUNDING; GENETICS; HUMAN; NON PROFIT ORGANIZATION; PATIENT CARE; PRACTICE GUIDELINE; PUBLIC-PRIVATE PARTNERSHIP; RESEARCH; REVIEW; SECONDARY PREVENTION; SOCIAL SUPPORT; SOCIOECONOMICS; UNITED STATES; HEALTH CARE POLICY; LEGISLATION AND JURISPRUDENCE; MEDICAL RESEARCH; PATHOLOGY;

ALZHEIMER DISEASE; BIOMEDICAL RESEARCH; DEMENTIA; HEALTH POLICY; HUMANS; PUBLIC-PRIVATE SECTOR PARTNERSHIPS; UNITED STATES;

EID: 84943457485     PISSN: 00982997     EISSN: 18729452     Source Type: Journal    
DOI: 10.1016/j.mam.2015.06.005     Document Type: Review

References (99)

1. M.S. Albert, S.T. Dekosky, D. Dickson, B. Dubois, H.H. Feldman, N.C. Fox, and et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 3 2011 270 279
2. P. Alexopoulos, L. Kriett, B. Haller, E. Klupp, K. Gray, T. Grimmer, and et al. Limited agreement between biomarkers of neuronal injury at different stages of Alzheimer's disease Alzheimers Dement 10 6 2014 684 689
3. Alzheimer's Association Über eine eigenartige Erkrankung der Hirnrinde Allg. Z Psychiatr Psychisch Gerichtl. Med 64 1907 146 148
4. Alzheimer's Association Global Alzheimer's Association Interactive Network http://www.gaain.org/ 2013
5. Alzheimer's Association 2014 Alzheimer's disease facts and figures Alzheimer Dement 10 2 2014 e47 e92
6. Alzheimer's Association Changing the trajectory of Alzheimer's disease: How a treatment by 2025 saves lives and dollars 2015
7. Alzheimer's Association Expert Advisory Group on NAPA Policy Forum: workgroup on NAPA's scientific agenda for a national initiative on Alzheimer's disease Alzheimer Dement 8 2012 357 371
8. Alzheimer's Association National Plan Milestone Workgroup K.N. Fargo, P. Aisen, M. Albert, R. Au, M.M. Corrada, and et al. 2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease Alzheimers Dement 10 Suppl. 5 2014 S430 S452
9. Alzheimer's Disease International World Alzheimer's Report 2009
10. Alzheimer's Disease International Alzheimer's Disease International Annual Report 2012-2013 2012-2013
11. Alzheimer's Study Group A national strategic plan: The report of the Alzheimer's Study Group http://www.alz.org/documents/national/report-ASG-alzplan.pdf 2009
12. C. Amador-Ortiz, Lin W.L., Z. Ahmed, D. Personett, P. Davies, R. Duara, and et al. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease Ann. Neurol 61 5 2007 435 445
13. R.J. Bateman, P.S. Aisen, B. De Strooper, N.C. Fox, C.A. Lemere, J.M. Ringman, and et al. Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease Alzheimers Res. Ther 3 1 2011 1
14. R.J. Bateman, Xiong C., T.L.S. Benzinger, A.M. Fagan, A. Goate, N.C. Fox, and et al. Clinical, cognitive, and biomarker changes in the Dominantly Inherited Alzheimer Network N. Engl. J. Med 367 9 2012 795 804
15. M. Bilgel, An Y., Lang A., J. Prince, L. Ferrucci, B. Jedynak, and et al. Trajectories of Alzheimer disease-related cognitive measures in a longitudinal sample Alzheimers Dement 10 6 2014 735 742 e734
16. A.M. Brickman, N. Schupf, J.J. Manly, Y. Stern, J.A. Luchsinger, F.A. Provenzano, and et al. APOE epsilon4 and risk for Alzheimer's disease: do regionally distributed white matter hyperintensities play a role? Alzheimers Dement 10 6 2014 619 629
17. M.C. Carrillo Leveraging global resources to end the Alzheimer's pandemic Alzheimers Dement 9 4 2013 363 365
18. M.C. Carrillo, L.J. Bain, G.B. Frisoni, and M.W. Weiner Worldwide Alzheimer's disease neuroimaging initiative Alzheimers Dement 8 4 2012 337 342
19. M.C. Carrillo, K. Blennow, H. Soares, P. Lewczuk, N. Mattsson, P. Oberoi, and et al. Global standardization measurement of cerebral spinal fluid for Alzheimer's disease: an update from the Alzheimer's Association Global Biomarkers Consortium Alzheimers Dement 9 2 2013 137 140
20. M.C. Carrillo, H.R. Brashear, V. Logovinsky, J.M. Ryan, H.H. Feldman, E.R. Siemers, and et al. Can we prevent Alzheimer's disease? Secondary "prevention" trials in Alzheimer's disease Alzheimers Dement 9 2 2013 123 131 e121
21. M.C. Carrillo, R.A. Dean, F. Nicolas, D.S. Miller, R. Berman, Z. Khachaturian, and et al. Revisiting the framework of the National Institute on Aging-Alzheimer's Association diagnostic criteria Alzheimers Dement 9 5 2013 594 601
22. C. Cerami, A. Dodich, N. Canessa, C. Crespi, A. Marcone, F. Cortese, and et al. Neural correlates of empathic impairment in the behavioral variant of frontotemporal dementia Alzheimers Dement 10 6 2014 827 834
23. D.W. Choi, R. Armitage, L.S. Brady, T. Coetzee, W. Fisher, S. Hyman, and et al. Medicines for the mind: policy-based "pull" incentives for creating breakthrough CNS drugs Neuron 84 3 2014 554 563
24. E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, G.W. Small, and et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 5123 1993 921 923
25. S. Cosentino, L.B. Zahodne, J. Brandt, D. Blacker, M. Albert, B. Dubois, and et al. Social cognition in Alzheimer's disease: a separate construct contributing to dependence Alzheimers Dement 10 6 2014 818 826
26. C. Cruchaga, C.M. Karch, Jin S.C., B.A. Benitez, Cai Y., R. Guerreiro, and et al. Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease Nature 505 7484 2014 550 554
27. Defense and Veterans Brain Injury Center (DVBIC) DoD Worldwide Numbers for TBI http://www.dvbic.org/dod-worldwide-numbers-tbi 2012 accessed 09.09.12
28. S.T. DeKosky, M.C. Carrillo, C. Phelps, D. Knopman, R.C. Petersen, R. Frank, and et al. Revision of the criteria for Alzheimer's disease: a symposium Alzheimers Dement 7 1 2011 e1 e12
29. D.W. Dickson, P. Davies, C. Bevona, K.H. Van Hoeven, S.M. Factor, E. Grober, and et al. Hippocampal sclerosis: a common pathological feature of dementia in very old (> or = 80 years of age) humans Acta Neuropathol 88 3 1994 212 221
30. D.W. Dickson, M. Baker, and R. Rademakers Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly Neurodegener Dis 7 1-3 2010 170 174
31. I.D. Dinov, P. Petrosyan, Liu Z., P. Eggert, S. Hobel, P. Vespa, and et al. High-throughput neuroimaging-genetics computational infrastructure Front. Neuroinform 8 2014 41
32. H.H. Dodge, Zhu J., D. Harvey, N. Saito, L.C. Silbert, J.A. Kaye, and et al. Biomarker progressions explain higher variability in stage-specific cognitive decline than baseline values in Alzheimer disease Alzheimers Dement 10 6 2014 690 703
33. B. Dubois, H.H. Feldman, C. Jacova, S.T. Dekosky, P. Barberger-Gateau, J. Cummings, and et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria Lancet Neurol 6 8 2007 734 746
34. F.H. Duits, C.E. Teunissen, F.H. Bouwman, P.J. Visser, N. Mattsson, H. Zetterberg, and et al. The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean? Alzheimers Dement 10 6 2014 713 723 e712
35. R. Egge The Alzheimer's Study Group's recommendations five years later: planning has advanced, but agenda remains unfinished Health Aff. (Millwood) 33 4 2014 555 560
36. H. Fischer U.S. Military Casualty Statistics: Operation New Dawn, Operation Iraqi Freedom, and Operation Enduring Freedom 2010 Congressional Research Service
37. M.T. Fodero-Tavoletti, S. Furumoto, L. Taylor, C.A. McLean, R.S. Mulligan, I. Birchall, and et al. Assessing THK523 selectivity for tau deposits in Alzheimer's disease and non-Alzheimer's disease tauopathies Alzheimers Res. Ther 6 1 2014 11
38. Food and Drug Administration Draft Guidance for Industry. Alzheimer's disease: Developing drugs for the treatment of early stage disease http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM338287.pdf 2013 accessed 24.04.13
39. G8 Health Ministers G8 Dementia Summit Declaration https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/265869/2901668-G8-DementiaSummitDeclaration-acc.pdf 2013
40. M. Gatz, C.A. Reynolds, L. Fratiglioni, B. Johansson, J.A. Mortimer, S. Berg, and et al. Role of genes and environments for explaining Alzheimer disease Arch. Gen. Psychiatry 63 2 2006 168 174
41. J.J. Gomar, C. Conejero-Goldberg, P. Davies, T.E. Goldberg Alzheimer's Disease Neuroimaging Initiative Extension and refinement of the predictive value of different classes of markers in ADNI: four-year follow-up data Alzheimers Dement 10 6 2014 704 712
42. R. Guerreiro, and J. Hardy TREM2 and neurodegenerative disease N. Engl. J. Med 369 16 2013 1569 1570
43. H. Hampel, R. Frank, K. Broich, S.J. Teipel, R.G. Katz, J. Hardy, and et al. Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives Nat. Rev. Drug Discov 9 7 2010 560 574
44. J.A. Hardy, and G.A. Higgins Alzheimer's disease: the amyloid cascade hypothesis Science 256 5054 1992 184 185
45. D. Hartley, T. Blumenthal, M. Carrillo, G. DiPaolo, L. Esralew, K. Gardiner, and et al. Down syndrome and Alzheimer's disease: common pathways, common goals Alzheimers Dement 11 6 2015 700 709
46. K.M. Hayden, O.A. Makeeva, L.K. Newby, B.L. Plassman, V.V. Markova, A. Dunham, and et al. A comparison of neuropsychological performance between US and Russia: preparing for a global clinical trial Alzheimers Dement 10 6 2014 760 768 e761
47. T.J. Hohman, M.E. Koran, T.A. Thornton-Wells Alzheimer's Disease Neuroimaging Initiative Genetic modification of the relationship between phosphorylated tau and neurodegeneration Alzheimers Dement 10 6 2014 637 645 e631
48. D. Holmes Mind the IGAP Lancet Neurol 10 6 2011 502 503
49. Innovative Medicines Initiative EMIF (European Medical Information Framework) http://www.emif.eu/ 2013
50. C.R. Jack Jr., D.S. Knopman, W.J. Jagust, L.M. Shaw, P.S. Aisen, M.W. Weiner, and et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade Lancet Neurol 9 1 2010 119 128
51. C.R. Jack Jr., M. Albert, D.S. Knopman, G.M. McKhann, R.A. Sperling, M.C. Carrillo, and et al. Introduction to revised criteria for the diagnosis of Alzheimer's disease: National Institute on Aging and the Alzheimer's Association workgroup Alzheimers Dement 7 3 2011 257 262
52. F. Jessen, R.E. Amariglio, M. van Boxtel, M. Breteler, M. Ceccaldi, G. Chetelat, and et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease Alzheimers Dement 10 6 2014 844 852
53. Y. Joanette, E.C. Hirsch, and M. Goldman The global fight against dementia Sci. Transl. Med 6 267 2014 267ed222
54. T. Jonsson, H. Stefansson, S. Steinberg, I. Jonsdottir, P.V. Jonsson, J. Snaedal, and et al. Variant of TREM2 associated with the risk of Alzheimer's disease N. Engl. J. Med 368 2 2013 107 116
55. K.A. Josephs, J.L. Whitwell, D.S. Knopman, Hu W.T., D.A. Stroh, M. Baker, and et al. Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype Neurology 70 19 Pt 2 2008 1850 1857
56. K.A. Josephs, J.R. Duffy, E.A. Strand, M.M. Machulda, M.L. Senjem, V.J. Lowe, and et al. APOE epsilon4 influences beta-amyloid deposition in primary progressive aphasia and speech apraxia Alzheimers Dement 10 6 2014 630 636
57. K.A. Josephs, M.E. Murray, J.L. Whitwell, J.E. Parisi, L. Petrucelli, C.R. Jack, and et al. Staging TDP-43 pathology in Alzheimer's disease Acta Neuropathol 127 3 2014 441 450
58. C.M. Karch, and A.M. Goate Alzheimer's disease risk genes and mechanisms of disease pathogenesis Biol. Psychiatry 77 1 2015 43 51
59. A.S. Khachaturian, and Z.S. Khachaturian Military risk factors for Alzheimer's dementia and neurodegenerative disease Alzheimers Dement 10 Suppl. 3 2014 S90 S91
60. Z.S. Khachaturian Perspective on the "2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease" Alzheimers Dement 10 Suppl. 5 2014 S265 S268
61. J.C. Lambert, C.A. Ibrahim-Verbaas, D. Harold, A.C. Naj, R. Sims, C. Bellenguez, and et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease Nat. Genet 45 12 2013 1452 1458
62. J. Lejeune, R. Turpin, and M. Gautier [Mongolism; a chromosomal disease (trisomy)] Bull. Acad. Natl Med 143 11-12 1959 256 265
63. C. Liggins, H.M. Snyder, N. Silverberg, S. Petanceska, L.M. Refolo, L. Ryan, and et al. International Alzheimer's Disease Research Portfolio (IADRP) aims to capture global Alzheimer's disease research funding Alzheimers Dement 10 3 2014 405 408
64. M.W. Logue, M. Schu, B.N. Vardarajan, J. Farrell, D.A. Bennett, J.D. Buxbaum, and et al. Two rare AKAP9 variants are associated with Alzheimer's disease in African Americans Alzheimers Dement 10 6 2014 609 618 e611
65. M. Mathews, E. Abner, R. Kryscio, G. Jicha, G. Cooper, C. Smith, and et al. Diagnostic accuracy and practice effects in the National Alzheimer's Coordinating Center Uniform Data Set neuropsychological battery Alzheimers Dement 10 6 2014 675 683
66. G.M. McKhann, D.S. Knopman, H. Chertkow, B.T. Hyman, C.R. Jack Jr., C.H. Kawas, and et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging and the Alzheimer's Association workgroup Alzheimers Dement 7 3 2011 263 269
67. D.M. Michaelson APOE epsilon4: the most prevalent yet understudied risk factor for Alzheimer's disease Alzheimers Dement 10 6 2014 861 868
68. S.M. Mills, J. Mallmann, A.M. Santacruz, A. Fuqua, M. Carril, P.S. Aisen, and et al. Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial Rev. Neurol. (Paris) 169 10 2013 737 743
69. J.L. Molinuevo, K. Blennow, B. Dubois, S. Engelborghs, P. Lewczuk, A. Perret-Liaudet, and et al. The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative Alzheimers Dement 10 6 2014 808 817
70. National Institute on Aging Recruiting older adults into research (ROAR) toolkit http://www.nia.nih.gov/health/publication/roar-toolkit 2014
71. P.T. Nelson, I. Alafuzoff, E.H. Bigio, C. Bouras, H. Braak, N.J. Cairns, and et al. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature J. Neuropathol. Exp. Neurol 71 5 2012 362 381
72. S. Ness, M. Rafii, P. Aisen, M. Krams, W. Silverman, and H. Manji Down's syndrome and Alzheimer's disease: towards secondary prevention Nat. Rev. Drug Discov 11 9 2012 655 656
73. OECD Emerging Trends in Biomedicine and Health Technology Innovation: Addressing the Global Challenge of Alzheimer's OECD Science, Technology and Industry Policy Papers. No. 6 2013
74. OECD Unlocking Global Collaboration to Accelerate Innovation for Alzheimer's Disease and Dementia Oxford University. DSTI/ICCP/IE(2013)13 2013
75. S.E. Parker, C.T. Mai, M.A. Canfield, R. Rickard, Wang Y., R.E. Meyer, and et al. Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006 Birth Defects Res. A. Clin Mol. Teratol 88 12 2010 1008 1016
76. B.L. Plassman, R.J. Havlik, D.C. Steffens, M.J. Helms, T.N. Newman, D. Drosdick, and et al. Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias Neurology 55 8 2000 1158 1166
77. E.M. Reiman, J.B. Langbaum, A.S. Fleisher, R.J. Caselli, Chen K., N. Ayutyanont, and et al. Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments J. Alzheimers Dis 26 Suppl. 3 2011 321 329
78. A.D. Roses, K.A. Welsh-Bohmer, K.L. Burns, C. Chiang, D.G. Crenshaw, M.W. Lutz, and et al. A pharmacogenetic-supported clinical trial to delay onset of mild cognitive impairment (MCI) due to Alzheimer's disease Poster #34249. Alzheimer's Association International Conference. Vancouver, Canada 2012
79. K. Rosow, A. Holzapfel, J.H. Karlawish, M. Baumgart, L.J. Bain, and A.S. Khachaturian Countrywide strategic plans on Alzheimer's disease: developing the framework for the international battle against Alzheimer's disease Alzheimers Dement 7 6 2011 615 621
80. C. Rupp, K. Beyreuther, K. Maurer, and S. Kins A presenilin 1 mutation in the first case of Alzheimer's disease: revisited Alzheimers Dement 10 6 2014 869 872
81. G.D. Schellenberg, and T.J. Montine The genetics and neuropathology of Alzheimer's disease Acta Neuropathol 124 3 2012 305 323
82. J.A. Schneider, Z. Arvanitakis, S.E. Leurgans, and D.A. Bennett The neuropathology of probable Alzheimer disease and mild cognitive impairment Ann. Neurol 66 2 2009 200 208
83. L.M. Shaw, H. Vanderstichele, M. Knapik-Czajka, C.M. Clark, P.S. Aisen, R.C. Petersen, and et al. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects Ann. Neurol 65 4 2009 403 413
84. C.F. Slattery, J.A. Beck, L. Harper, G. Adamson, Z. Abdi, J. Uphill, and et al. R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia Alzheimers Dement 10 6 2014 602 608 e604
85. H.M. Snyder, H. Kim, L.J. Bain, R. Egge, and M.C. Carrillo Alzheimer's disease public-private partnerships: update 2014 Alzheimers Dement 10 6 2014 873 880
86. H.M. Snyder, M.C. Carrillo, F. Grodstein, K. Henriksen, A. Jeromin, S. Lovestone, and et al. Developing novel blood-based biomarkers for Alzheimer's disease Alzheimers Dement 10 1 2014 109 114
87. P.J. Snyder, K. Kahle-Wrobleski, S. Brannan, D.S. Miller, R.J. Schindler, S. DeSanti, and et al. Assessing cognition and function in Alzheimer's disease clinical trials: do we have the right tools? Alzheimers Dement 10 6 2014 853 860
88. R.A. Sperling, P.S. Aisen, L.A. Beckett, D.A. Bennett, S. Craft, A.M. Fagan, and et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging and the Alzheimer's Association workgroup Alzheimers Dement 7 3 2011 280 292
89. C.E. Stephens, R. Newcomer, M. Blegen, B. Miller, and C. Harrington The effects of cognitive impairment on nursing home residents' emergency department visits and hospitalizations Alzheimers Dement 10 6 2014 835 843
90. D.R. Thal, C. von Arnim, W.S. Griffin, H. Yamaguchi, R.E. Mrak, J. Attems, and et al. Pathology of clinical and preclinical Alzheimer's disease Eur. Arch. Psychiatry Clin. Neurosci 263 Suppl. 2 2013 S137 S145
91. U.S. Department of Health and Human Services National Plan to Address Alzheimer's Disease: 2012 http://aspe.hhs.gov/daltcp/napa/natlplan.pdf 2013
92. J.M. Wardlaw, E.E. Smith, G.J. Biessels, C. Cordonnier, F. Fazekas, R. Frayne, and et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration Lancet Neurol 12 8 2013 822 838
93. M.W. Weiner, D.P. Veitch, P.S. Aisen, L.A. Beckett, N.J. Cairns, R.C. Green, and et al. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception Alzheimers Dement 8 Suppl. 1 2012 S1 S68
94. M.W. Weiner, K.E. Friedl, A. Pacifico, J.C. Chapman, M.S. Jaffee, D.M. Little, and et al. Military risk factors for Alzheimer's disease Alzheimers Dement 9 4 2013 445 451
95. M.W. Weiner, D.P. Veitch, P.S. Aisen, L.A. Beckett, N.J. Cairns, R.C. Green, and et al. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception Alzheimers Dement 9 5 2013 e111 e194
96. M.W. Weiner, D.P. Veitch, J. Hayes, T. Neylan, J. Grafman, P.S. Aisen, and et al. Effects of traumatic brain injury and posttraumatic stress disorder on Alzheimer's disease in veterans, using the Alzheimer's Disease Neuroimaging Initiative Alzheimers Dement 10 Suppl. 3 2014 S226 S235
97. D.M. Wilcock Neuroinflammation in the aging down syndrome brain; lessons from Alzheimer's disease Curr. Gerontol. Geriatr. Res 2012 2012 170276
98. World Health Organization and Alzheimer's Disease International Dementia: a public health priority 2012
99. K. Yaffe, E. Vittinghoff, K. Lindquist, D. Barnes, K.E. Covinsky, T. Neylan, and et al. Posttraumatic stress disorder and risk of dementia among US veterans Arch. Gen. Psychiatry 67 6 2010 608 613